Search results
What Makes Vir Biotechnology (VIR) a New Buy Stock
Zacks via Yahoo Finance· 1 day agoVir Biotechnology (VIR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
UNITY Biotechnology Announces Upcoming Presentations at the ARVO 2024 Annual Meeting
Morningstar· 9 hours agoSOUTH SAN FRANCISCO, Calif., April 25, 2024 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics ...
3 Millionaire-Maker Biotech Stocks
Motley Fool via Yahoo Finance· 7 hours agoAlthough the COVID-19 pandemic sparked bullish interest in the industry, this interest has waned since the contagion began winding down. Between late...
Making sustainable biotechnology a reality: Joined forces aim to improve biocatalysts
Phys.org· 7 hours agoA collaboration of researchers now proposes an idea to accelerate the development process. By combining machine learning and laboratory automation, this biobased ideal may become a reality sooner rather than later.
Heron Therapeutics, Inc.'s (NASDAQ:HRTX) Profit Outlook
Simply Wall St. via Yahoo Finance· 11 hours agos (NASDAQ:HRTX) future prospects. Heron Therapeutics, Inc., a commercial-stage biotechnology...
Monica A. Kolinsky, Ph.D.
The National Law Review· 3 hours agoMonica is an Associate in the Corporate Department and a member of the Life Sciences Practice Group, and is based in the firm’s Stamford office. Before joining the firm, Monica was of counsel ...
CollPlant Biotechnologies (NASDAQ:CLGN) Is In A Strong Position To Grow Its Business
Simply Wall St. via Yahoo Finance· 2 days agoThere's no doubt that money can be made by owning shares of unprofitable businesses. For example,...
AstraZeneca CEO on US-China tensions: 'We have established a very resilient supply chain'
Yahoo Finance· 2 hours ago(Photo by Peter Byrne/PA Images via Getty Images) Peter Byrne - PA Images via Getty Images US-based ...
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Shares Sold by Duality Advisers LP
ETF DAILY NEWS· 14 hours ago(NASDAQ:IRWD – Free Report) by 12.1% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 64,842 shares of the biotechnology ...
Cidara shares soar over 19% amid strategic shift, Needham raises PT to $25 from $3 By Investing.com
Investing.com· 8 hours agoThe investment firm maintained its Buy rating on the biotechnology company's stock. This adjustment...
